TAL's $11.80 Challenger bid arrives as annuity momentum builds

TAL Daiichi Life Australia has tabled a conditional $11.80-per-share proposal to acquire the 79.5% of Challenger it does not already own. The approach arrives as Challenger reports a 52% jump in first-quarter sales, but remains non-binding and subject to due diligence, regulatory approval and a board recommendation.

  • $11.80 per share indicative offer from TAL Daiichi Life Australia
  • 17.7% premium to Challenger's one-month VWAP
  • Challenger board is still considering the proposal
  • First-quarter sales rose 52% to $4.4 billion
  • Net annuity flows reached $1.1 billion
An image related to Challenger Limited Add us as a preferred source on Google
Image © middle. Logo © respective owner.

TAL places Challenger takeover proposal on the table

Challenger Limited (ASX:CGF) is facing a potential change of ownership after TAL Daiichi Life Australia, a subsidiary of Daiichi Life Group, proposed paying $11.80 per share for the 79.5% of Challenger it does not already own.

The proposal would take TAL to 100% ownership through a scheme of arrangement. Challenger said the price represents a 17.7% premium to its one-month volume-weighted average price of $10.03, giving shareholders a clear reference point even as the approach remains preliminary.

Offer still depends on several major conditions

This is not yet a binding takeover offer. TAL's proposal is conditional on satisfactory due diligence, agreement on a scheme implementation agreement, regulatory approvals and a recommendation from Challenger's board. Challenger said its directors are considering the approach and that shareholders do not need to take action at this stage.

That leaves the proposed $11.80 consideration as an indicative price rather than a secured exit value. The board has not recommended the proposal, and Challenger explicitly warned that there is no certainty a binding offer will emerge or that any transaction will proceed.

Annuity sales provide a stronger backdrop

The approach coincides with a strong first-quarter operating update. Challenger reported total sales of $4.4 billion, up 52% on the prior corresponding period, while total assets under management rose 5% during the quarter to $31.9 billion.

Annuity sales increased 72% to $2.8 billion, led by fixed-term sales of $2.2 billion, which more than doubled. Offshore reinsurance sales rose 30% to $320 million, supported by demand for yen-denominated annuities in Japan. Lifetime sales were $314 million, down 2%.

Net flows strengthen Challenger's retirement platform

After maturities and repayments, net annuity flows reached $1.1 billion, equivalent to 6.3% growth in the annuity book for the quarter. Total net flows, including Index Plus and LiFTS, were $1.8 billion, representing 7.7% growth in the combined book.

Challenger said the launch of its $6 billion Challenger Annuity-Backed Notes program had created another funding channel for annuity growth. The inaugural $750 million, three-year wholesale note was issued in July, while the Reserve Bank of Australia's approval of repurchase agreement eligibility has further enhanced the program's appeal, according to the company.

Fidante merger remains a separate strategic milestone

The quarterly update also said the proposed merger of Fidante and Channel Capital remains on track for completion later this half, subject to regulatory approvals and separation work. Following the earlier Fidante merger announcement, Challenger is expected to own 45% of the merged investment-management business.

Fidante's funds under management fell 5% during the quarter to $85 billion, with net outflows of $3.3 billion. Equity strategies accounted for most of the outflows, partly offset by $1.3 billion of inflows into alternatives. The figures highlight the contrast between Challenger's growing retirement-income book and the pressure still present in parts of its funds-management operations.

Bottom Line?

The immediate question is whether TAL turns a sizeable indicative premium into a binding scheme, while Challenger's board weighs that proposal against improving annuity momentum and a still-evolving standalone strategy.

Questions in the middle?

  • Will Challenger's board recommend TAL's $11.80-per-share proposal after due diligence and negotiations?
  • Can TAL secure the regulatory approvals required to acquire full ownership of the APRA-regulated life company?
  • Will Challenger's strong annuity inflows continue to lift the value of the standalone business before the offer terms are finalised?

Sources

2